Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,809,236 | 1,277,080 | 1,518,999 | 1,342,062 | 1,752,946 |
| Marketable Securities | 505,175 | 469,350 | 264,267 | N/A | N/A |
| Receivables | 3,592,174 | 3,687,848 | 3,935,797 | 3,913,431 | 4,225,349 |
| Inventories | 2,422,068 | 2,237,698 | 2,358,521 | 2,419,291 | 2,411,174 |
| Other current assets | 4,068 | 174,232 | 549,376 | 0 | 1 |
| TOTAL | $8,936,250 | $8,573,201 | $9,417,537 | $8,643,160 | $9,426,044 |
| Non-Current Assets | |||||
| PPE Net | 3,944,392 | 3,945,473 | 4,094,103 | 4,375,266 | 5,010,460 |
| Investments And Advances | 1,497,389 | 1,532,997 | 1,357,758 | 815,196 | 930,987 |
| Intangibles | 16,773,999 | 17,898,724 | 17,330,147 | 18,237,668 | 18,717,788 |
| Other Non-Current Assets | 3,924,010 | 4,371,996 | 4,522,692 | 5,599,250 | 6,573,795 |
| TOTAL | $26,139,790 | $27,749,190 | $27,304,700 | $29,027,380 | $31,233,030 |
| Total Assets | $35,076,040 | $36,322,390 | $36,722,230 | $37,670,540 | $40,659,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,824,998 | 29,217 | 1,022,344 | 1,436,136 | 2,276,070 |
| Accounts payable and accrued liabilities | 945,337 | 1,065,135 | 957,997 | 981,258 | 1,014,539 |
| Other current liabilities | 3,476,374 | 3,586,965 | 3,759,492 | 3,534,980 | 4,350,111 |
| TOTAL | $7,065,709 | $6,124,751 | $6,614,574 | $6,813,962 | $8,586,507 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,439,761 | 6,774,839 | 7,532,660 | 7,555,085 | 7,864,005 |
| Other Non-Current Liabilities | 4,389,998 | 5,372,991 | 5,463,531 | 5,804,804 | 6,347,055 |
| TOTAL | $11,850,760 | $13,134,540 | $14,060,900 | $14,579,320 | $15,533,970 |
| Total Liabilities | $18,916,470 | $19,259,290 | $20,675,470 | $21,393,280 | $24,120,480 |
| Shareholders' Equity | |||||
| Common Shares | 331,968 | 317,502 | 317,561 | 309,140 | 346,653 |
| Retained earnings | 13,812,030 | 12,191,250 | 11,820,540 | 11,285,860 | 12,808,410 |
| Other shareholders' equity | -805,425 | 934,292 | 250,127 | 1,128,669 | -37,132 |
| TOTAL | $16,159,570 | $17,063,110 | $16,046,760 | $16,277,250 | $16,538,600 |
| Total Liabilities And Equity | $35,076,040 | $36,322,400 | $36,722,230 | $37,670,530 | $40,659,080 |